Abstract: This retrospective cohort study explores the use of Bruton tyrosine kinase inhibitors (BTKi) in veterans with chronic lymphocytic leukaemia (CLL) and severe renal …
Abstract: Introduction: The KRAS G12C inhibitor sotorasib was approved for treating advanced NSCLC in the second line or later on the basis of the CodeBreaK100 trial. Nevertheless, …